Natural soluble epoxide hydrolase inhibitors from Inula helenium and their interactions with soluble epoxide hydrolase.

Kinetics Molecular stimulation Soluble epoxide hydrolase

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
29 Apr 2020
Historique:
received: 06 02 2020
revised: 15 03 2020
accepted: 25 04 2020
entrez: 4 5 2020
pubmed: 4 5 2020
medline: 4 5 2020
Statut: aheadofprint

Résumé

The inhibition of soluble epoxide hydrolase (sEH) is regarded as a promising therapeutic approach to treat inflammation and its related disorders. In present work, we investigated inhibitory effects of forty-nine kinds of traditional Chinese medicines against sEH. Inula helenium showed significant inhibitory effect against sEH, and the extract of I. helenium were isolated to obtain eight compounds, including 4H-tomentosin (1), xanthalongin (2), and linoleic acid (3), 8-hydroxy-9-isobutyryloxy-10(2)-methylbutyrylthymol (4), dehydrocostus lactone (5), alantolactone (6), costunolide (7), and isoalantolactone (8). Among them, 4H-tomentosin (1), xanthalongin (2), and linoleic acid (3) showed significantly inhibitory activities on sEH with half maximal inhibitory concentration (IC

Identifiants

pubmed: 32360461
pii: S0141-8130(20)33090-7
doi: 10.1016/j.ijbiomac.2020.04.227
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing financial interest.

Auteurs

Xin He (X)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.

Wen-Yu Zhao (WY)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.

Bo Shao (B)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.

Bao-Jing Zhang (BJ)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.

Tian-Tian Liu (TT)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.

Cheng-Peng Sun (CP)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China. Electronic address: suncp146@163.com.

Hui-Lian Huang (HL)

Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Jia-Rong Wu (JR)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.

Jia-Hao Liang (JH)

Zhendong Pharmaceutical Research Institute Co. Ltd., Changzhi, China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.

Xiao-Chi Ma (XC)

College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China. Electronic address: maxiaochi2019@163.com.

Classifications MeSH